Advertisement

---

ACCESS PHARMACEUTICALS, INC.

Access Pharmaceuticals Announces Positive Top-Line Data From MuGard™ Phase IV Clinical Trial In Oral Mucositis Patients Presented At MASCC/ISOO 2013 Symposium

[2013-06-27] - Met Primary Endpoint of Statistically Significant Reduction in Mouth and Throat Soreness Associated With Oral Mucositis; MuGard Patients Also Had Decreased Severity of Oral Mucositis by WHO Score


Access Pharmaceuticals Signs US License Agreement With AMAG Pharmaceuticals For MuGard

[2013-06-10] -


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers